Moreover, the SLC25A1 inhibition enhanced the sensitivity to cisplatin in ovarian carcinoma cells and increased the radiosensitivity of hypoxic lung cancer cells [14]. This evidence concerns the gene SLC25A1 and ovarian carcinoma.